| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,395 |
14,124 |
$1.86M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,054 |
4,417 |
$774K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,218 |
1,042 |
$335K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,954 |
2,607 |
$285K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
865 |
730 |
$49K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
269 |
242 |
$41K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
293 |
269 |
$39K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
990 |
895 |
$34K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,440 |
2,195 |
$24K |
| 93975 |
|
107 |
97 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,548 |
1,341 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
244 |
209 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
253 |
218 |
$6K |
| 81025 |
|
1,663 |
1,357 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
785 |
642 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
55 |
54 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
733 |
661 |
$2K |
| 87081 |
|
876 |
768 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,000 |
804 |
$2K |
| 93976 |
|
116 |
89 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
68 |
52 |
$877.58 |
| 36415 |
Collection of venous blood by venipuncture |
1,077 |
888 |
$858.70 |
| 83690 |
|
729 |
611 |
$676.47 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
53 |
48 |
$622.46 |
| 81001 |
|
1,860 |
1,544 |
$581.49 |
| 87088 |
|
1,262 |
1,089 |
$513.52 |
| 71045 |
Radiologic examination, chest; single view |
1,795 |
1,576 |
$500.66 |
| 87631 |
|
54 |
52 |
$429.11 |
| 74018 |
|
54 |
50 |
$417.81 |
| 87430 |
|
2,020 |
1,813 |
$378.74 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
522 |
413 |
$362.34 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,298 |
1,867 |
$274.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
321 |
272 |
$245.61 |
| 73630 |
|
16 |
16 |
$118.32 |
| 73610 |
|
33 |
30 |
$78.88 |
| 73110 |
|
39 |
34 |
$78.88 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
707 |
577 |
$35.55 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
289 |
238 |
$0.00 |
| 87070 |
|
433 |
419 |
$0.00 |
| 83735 |
|
95 |
82 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
760 |
645 |
$0.00 |
| 84484 |
|
486 |
356 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
17 |
13 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
518 |
425 |
$0.00 |
| 85652 |
|
61 |
58 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
33 |
26 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
119 |
99 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
42 |
36 |
$0.00 |
| 84704 |
|
119 |
78 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
548 |
437 |
$0.00 |
| 83605 |
|
33 |
24 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
145 |
116 |
$0.00 |
| 86140 |
|
72 |
67 |
$0.00 |
| 85730 |
|
48 |
45 |
$0.00 |
| 82550 |
|
12 |
12 |
$0.00 |
| 83880 |
|
16 |
13 |
$0.00 |
| 85379 |
|
46 |
42 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
129 |
123 |
$0.00 |
| 82962 |
|
74 |
55 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
21 |
15 |
$0.00 |
| 87077 |
|
27 |
24 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
76 |
49 |
$0.00 |
| 86901 |
|
19 |
16 |
$0.00 |
| 99292 |
|
19 |
16 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
382 |
315 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
284 |
241 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
145 |
116 |
$0.00 |
| 81003 |
|
433 |
379 |
$0.00 |
| 80076 |
|
311 |
244 |
$0.00 |
| 93308 |
|
12 |
12 |
$0.00 |
| 73130 |
|
12 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
21 |
16 |
$0.00 |
| 87210 |
|
177 |
151 |
$0.00 |
| 80305 |
|
97 |
78 |
$0.00 |
| 85610 |
|
100 |
82 |
$0.00 |
| 69210 |
|
35 |
32 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
12 |
$0.00 |
| 82248 |
|
13 |
12 |
$0.00 |
| 87186 |
|
14 |
13 |
$0.00 |